159 related articles for article (PubMed ID: 2963611)
21. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count.
Eyster ME; Ballard JO; Gail MH; Drummond JE; Goedert JJ
Ann Intern Med; 1989 Jun; 110(12):963-9. PubMed ID: 2567142
[TBL] [Abstract][Full Text] [Related]
22. Natural history of acquired immunodeficiency syndrome in hemophilic patients.
Kim HC; Nahum K; Raska K; Gocke DJ; Kosmin M; Karp GI; Saidi P
Am J Hematol; 1987 Feb; 24(2):169-76. PubMed ID: 3101490
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological evidence that HTLV-III is the AIDS agent.
Goedert JJ; Gallo RC
Eur J Epidemiol; 1985 Sep; 1(3):155-9. PubMed ID: 2945735
[TBL] [Abstract][Full Text] [Related]
24. Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population.
Carr R; Veitch SE; Edmond E; Peutherer JF; Prescott RJ; Steel CM; Ludlam CA
Lancet; 1984 Jun; 1(8392):1431-4. PubMed ID: 6145879
[TBL] [Abstract][Full Text] [Related]
25. Immunologic studies in asymptomatic hemophilia patients. Relationship to acquired immune deficiency syndrome (AIDS).
Landay A; Poon MC; Abo T; Stagno S; Lurie A; Cooper MD
J Clin Invest; 1983 May; 71(5):1500-4. PubMed ID: 6222070
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
Verani P; Mariani G; Mannucci PM; De Rossi G; Nicoletti L; Titti F; Falcione E; Pasqualetti D; Ammassari M; Gringeri A
J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059
[TBL] [Abstract][Full Text] [Related]
27. Heterosexual transmission of human immunodeficiency virus: association with severe depletion of T-helper lymphocytes in men with hemophilia.
Goedert JJ; Eyster ME; Biggar RJ; Blattner WA
AIDS Res Hum Retroviruses; 1987; 3(4):355-61. PubMed ID: 3502325
[TBL] [Abstract][Full Text] [Related]
28. Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients.
Kitchen L; Malone G; Orgad S; Barin F; Zaizov R; Ramot B; Gazit E; Kreiss J; Leal M; Wichmann I
J Infect Dis; 1986 Apr; 153(4):788-90. PubMed ID: 3005438
[No Abstract] [Full Text] [Related]
29. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States.
Goldsmith JC; Dewhurst S; Hedenskog M; Casareale D; Volsky DJ
Am J Med; 1986 Oct; 81(4):579-83. PubMed ID: 3532787
[TBL] [Abstract][Full Text] [Related]
30. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A.
Shannon BT; Roach J; Cheek-Luten M; Ruymann FB
Diagn Immunol; 1986; 4(1):37-42. PubMed ID: 3006971
[TBL] [Abstract][Full Text] [Related]
31. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
[TBL] [Abstract][Full Text] [Related]
32. Defect in B cell function in HTLV III/LAV positive hemophilia patients.
Sjamsoedin-Visser EJ; Heijnen CJ; Zegers BJ; Stoop JW
Blood; 1987 May; 69(5):1388-93. PubMed ID: 2952185
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a distinct subgroup of high-risk persons with Kaposi's sarcoma and good prognosis who present with normal T4 cell number and T4:T8 ratio and negative HTLV-III/LAV serologic test results.
Afrasiabi R; Mitsuyasu RT; Nishanian P; Schwartz K; Fahey JL
Am J Med; 1986 Dec; 81(6):969-73. PubMed ID: 2948385
[TBL] [Abstract][Full Text] [Related]
34. The acquired immunodeficiency syndrome in persons with hemophilia.
Levine PH
Ann Intern Med; 1985 Nov; 103(5):723-6. PubMed ID: 2996407
[TBL] [Abstract][Full Text] [Related]
35. [Epidemiology of infection by LAV/HTLV-III virus in hemophiliacs multitransfused in France. Results of a survey conducted by 28 hemophilia centers].
Sultan Y
Nouv Rev Fr Hematol (1978); 1986; 28(5):327-9. PubMed ID: 3643509
[TBL] [Abstract][Full Text] [Related]
36. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
[TBL] [Abstract][Full Text] [Related]
37. [Retrospective serological analysis of HTLV-III/LAV antibody and immunity in hemophiliac patients in Shizuoka Prefecture].
Mimaya J; Tonouchi T; Toyoda Y; Sugiyama T; Sonoda A; Fukuda F; Hattori T; Takatsuki K
Rinsho Ketsueki; 1986 Jun; 27(6):866-71. PubMed ID: 3463806
[No Abstract] [Full Text] [Related]
38. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
[TBL] [Abstract][Full Text] [Related]
39. Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome.
Burger H; Weiser B; Robinson WS; Lifson J; Engleman E; Rouzioux C; Brun-Vézinet F; Barré-Sinoussi F; Montagnier L; Chermann JC
Ann Intern Med; 1985 Oct; 103(4):545-7. PubMed ID: 2994532
[TBL] [Abstract][Full Text] [Related]
40. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS.
Chorba TL; Jason JM; Ramsey RB; Lechner K; Pabinger-Fasching I; Kalyanaraman VS; McDougal JS; Cabradilla CD; Tregillus LC; Lawrence DN
Thromb Haemost; 1985 Apr; 53(2):180-2. PubMed ID: 2992112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
